University of Washington, the Collaborative Health Studies Coordinating Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Washington, the Collaborative Health Studies Coordinating Center sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).

5 total trials 1 currently recruiting 3 completed early-phase tilt upper quartile by trial count

University of Washington, the Collaborative Health Studies Coordinating Center: 5 sponsored US clinical trials, 1 recruiting.

University of Washington, the Collaborative Health Studies Coordinating Center sponsors 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cystic Fibrosis, with 3 trials.

Upper-quartile sponsor footprint

University of Washington, the Collaborative Health Studies Coordinating Center sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

5 total, page 1 of 1

RECRUITING NA

Streamlined Treatment of Pulmonary Exacerbations in Pediatrics

NCT06654752
ACTIVE NOT RECRUITING

Colorectal Cancer Screening in Cystic Fibrosis

NCT05362344
COMPLETED NA

Streamlined Treatment of Pulmonary Exacerbations in Pediatrics Pilot Study

NCT04608019
COMPLETED Phase 2

Saline Hypertonic in Preschoolers + CT

NCT02950883
COMPLETED NA

Saline Hypertonic in Preschoolers

NCT02378467

Phase Distribution

PhaseTrial count
Phase 2 1

Therapeutic Areas

Cystic Fibrosis 3
Adenoma 1
Colorectal Cancer 1

What is open in the University of Washington, the Collaborative Health Studies Coordinating Center pipeline

1 recruiting of 5 indexed (20% open); 3 completed (60%).

Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).

Top condition: Cystic Fibrosis (3 trials), 2 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Washington, the Collaborative Health Studies Coordinating Center: open-pipeline peers nationwide

Peers matched on 5 registered trials and 20% open enrollment, not the therapeutic-area sidebar.

University of Washington, the Collaborative Health Studies Coordinating Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 4.95.05.055.05.05.1 0%5%10%15%20%25% Total trials Recruiting share University of Washington, the Collaborative Health Studies Coordinating Center4YouandMeAbbott Rapid DxAccess Business GroupAcera SurgicalAlign TechnologyAltruBioAlvernia UniversityAmazentis
University of Washington, the Collaborative Health Studies Coordinating Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Washington, the Collaborative Health Studies Coordinating Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 5 trials (± recruiting share)

Sponsors near 20% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Washington, the Collaborative Health Studies Coordinating Center page

5 registered trials is a research-attention snapshot, not an endorsement of University of Washington, the Collaborative Health Studies Coordinating Center or any single study.

  • 1 of University of Washington, the Collaborative Health Studies Coordinating Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Cystic Fibrosis is the condition University of Washington, the Collaborative Health Studies Coordinating Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cystic Fibrosis trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Washington, the Collaborative Health Studies Coordinating Center pipeline card: 5 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.